Carters vs KinderCare Learning Companies
CRI and KLC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRI and KLC compare
Carters is the larger company, worth 7.7 times as much as KinderCare Learning Companies ($1.3B against $162M).
Carters grew revenue faster over the last twelve months (5.0% versus 1.2% for KinderCare Learning Companies).
Carters keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with −20.6% at KinderCare Learning Companies.
Carters pays a dividend yielding 2.9%; KinderCare Learning Companies does not pay one.
Carters scores higher on the StockData Score (21 against 3 for KinderCare Learning Companies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRI | KLC |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $162M |
| Share price | $34.29 | $1.37 |
| Change, 1 year | 3.3% | −72.6% |
| Change, 5 years | −67.9% | – |
| Beta (5Y) | 0.93 | 1.14 |
| Employees | 15K | 44K |
| StockData Score | ||
| Total score | 21 (better) | 3 |
| Valuation score | 6 (better) | 3 |
| Growth score | 3 (better) | 0 |
| Performance score | 5 (better) | 0 |
| Health score | 4 (better) | 0 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 5.7× | – |
| P/S | 0.4× | 0.1× (better) |
| P/B | 1.2× | 0.4× (better) |
| EV/EBITDA | 3.6× | – |
| P/FCF | 3.9× | – |
| FCF yield | 25.4% (better) | −4.9% |
| Fair value | $79.70 | $11.44 |
| Margin of safety | 57.0% | 88.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.0% (better) | 1.2% |
| Revenue growth, 5Y average | −0.85% | – |
| Net income growth (TTM) | 147% | – |
| EPS growth (TTM) | 145% | – |
| EPS growth, 5Y average | 0.24% | – |
| Profitability | ||
| Gross margin | 49.1% (better) | 18.5% |
| Operating margin | 10.4% (better) | −18.7% |
| Net margin | 7.4% (better) | −20.6% |
| FCF margin | 10.7% (better) | −0.29% |
| Return on equity | 22.9% (better) | −85.2% |
| Return on invested capital | 21.3% (better) | −28.2% |
| Financial health | ||
| Debt / equity | 0.54 (better) | 2.40 |
| Net debt / EBITDA | 0.12 | – |
| Interest coverage | 6.7× (better) | −6.8× |
| Current ratio | 2.78 (better) | 0.77 |
| Altman Z-score | 2.93 (better) | 0.10 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.9% | – |
| Payout ratio | 16.6% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 20.9% | – |
| Shareholder yield | 2.9% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 107% | 91.8% |
| Held by insiders | 3.6% | 5.5% |
| Insider net buying, 12 months | – | $1.1M |
| Short interest, % of float | 17.6% | 3.2% |
Go deeper
- CRI stock overview
- CRI income statement
- CRI valuation and score
- KLC stock overview
- KLC income statement
- KLC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.